The aim of the present pilot study is to evaluate the association between change in gait
related mobility in ambulatory male and female adult hemiparetic patients before and
4-6-weeks after Xeomin® injection into the upper limb, using two standardized tests of
physical function in outpatient rehabilitation that are widely used; the 10-meter walk test
and the timed 'up and go' test (TUG).